Literature DB >> 34391575

Feasibility, Methodology, and Interpretation of Broad-Scale Assessment of Cardiorespiratory Fitness in a Large Community-Based Sample.

Matthew Nayor1, Ravi V Shah2, Melissa Tanguay2, Jasmine B Blodgett2, Ariel Chernofsky3, Patricia E Miller3, Vanessa Xanthakis4, Rajeev Malhotra5, Nicholas E Houstis2, Raghava S Velagaleti6, Martin G Larson7, Ramachandran S Vasan8, Gregory D Lewis9.   

Abstract

Cardiorespiratory fitness (CRF) is intricately related to health status. The optimal approach for CRF quantification is through assessment of peak oxygen uptake (VO2), but such measurements have been largely confined to small referral populations. Here we describe protocols and methodological considerations for peak VO2 assessment and determination of volitional effort in a large community-based sample. Maximum incremental ramp cycle ergometry cardiopulmonary exercise testing (CPET) was performed by Framingham Heart Study participants at a routine study visit (2016 to 2019). Of 3,486 individuals presenting for a multicomponent study visit, 3,116 (89%) completed CPET. The sample was middle-aged (54 ± 9 years), with 53% women, body mass index 28.3 ± 5.6 kg/m2, 48% with hypertension, 6% smokers, and 8% with diabetes. Exercise duration was 12.0 ± 2.1 minutes (limits 3.7to20.5). No major cardiovascular events occurred. A total of 98%, 96%, 90%, 76%, and 57% of the sample reached peak respiratory exchange ratio (RER) values of ≥1.0, ≥1.05, ≥1.10, ≥1.15, and ≥1.20, respectively (mean peak RER = 1.21 ± 0.10). With rising peak RER values up to ≈1.10, steep changes were observed for percent predicted peak VO2, VO2 at the ventilatory threshold/peak VO2, heart rate response, and Borg (subjective dyspnea) scores. More shallow changes for effort dependent CPET variables were observed with higher achieved RER values. In conclusion, measurement of peak VO2 is feasible and safe in a large sample of middle-aged, community-dwelling individuals with heterogeneous cardiovascular risk profiles. Peak RER ≥1.10 was achievable by the majority of middle-aged adults and RER values beyond this threshold did not necessarily correspond to higher peak VO2 values.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34391575      PMCID: PMC9252421          DOI: 10.1016/j.amjcard.2021.07.020

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   3.133


  29 in total

Review 1.  Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association.

Authors:  Gary J Balady; Ross Arena; Kathy Sietsema; Jonathan Myers; Lola Coke; Gerald F Fletcher; Daniel Forman; Barry Franklin; Marco Guazzi; Martha Gulati; Steven J Keteyian; Carl J Lavie; Richard Macko; Donna Mancini; Richard V Milani
Journal:  Circulation       Date:  2010-06-28       Impact factor: 29.690

2.  Epidemiological approaches to heart disease: the Framingham Study.

Authors:  T R DAWBER; G F MEADORS; F E MOORE
Journal:  Am J Public Health Nations Health       Date:  1951-03

3.  Midlife Cardiorespiratory Fitness and the Long-Term Risk of Mortality: 46 Years of Follow-Up.

Authors:  Johan S R Clausen; Jacob L Marott; Andreas Holtermann; Finn Gyntelberg; Magnus T Jensen
Journal:  J Am Coll Cardiol       Date:  2018-08-28       Impact factor: 24.094

4.  Variables Measured During Cardiopulmonary Exercise Testing as Predictors of Mortality in Chronic Systolic Heart Failure.

Authors:  Steven J Keteyian; Mahesh Patel; William E Kraus; Clinton A Brawner; Timothy R McConnell; Ileana L Piña; Eric S Leifer; Jerome L Fleg; Gordon Blackburn; Gregg C Fonarow; Paul J Chase; Lucy Piner; Marianne Vest; Christopher M O'Connor; Jonathan K Ehrman; Mary N Walsh; Gregory Ewald; Dan Bensimhon; Stuart D Russell
Journal:  J Am Coll Cardiol       Date:  2016-02-23       Impact factor: 24.094

5.  The safety of cardiopulmonary exercise testing in a population with high-risk cardiovascular diseases.

Authors:  Joseph Skalski; Thomas G Allison; Todd D Miller
Journal:  Circulation       Date:  2012-10-22       Impact factor: 29.690

6.  Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction.

Authors:  Steven J Keteyian; Debra Isaac; Udho Thadani; Brad A Roy; Daniel R Bensimhon; Robert McKelvie; Stuart D Russell; Anne S Hellkamp; William E Kraus
Journal:  Am Heart J       Date:  2009-10       Impact factor: 4.749

7.  Relation of oxygen uptake to work rate in normal men and men with circulatory disorders.

Authors:  J E Hansen; D Y Sue; A Oren; K Wasserman
Journal:  Am J Cardiol       Date:  1987-03-01       Impact factor: 2.778

8.  New Data-based Cutoffs for Maximal Exercise Criteria across the Lifespan.

Authors:  Jonathan Wagner; Max Niemeyer; Denis Infanger; Timo Hinrichs; Lukas Streese; Henner Hanssen; Jonathan Myers; Arno Schmidt-Trucksäss; Raphael Knaier
Journal:  Med Sci Sports Exerc       Date:  2020-09       Impact factor: 5.411

9.  An investigation of coronary heart disease in families. The Framingham offspring study.

Authors:  W B Kannel; M Feinleib; P M McNamara; R J Garrison; W P Castelli
Journal:  Am J Epidemiol       Date:  1979-09       Impact factor: 4.897

10.  Metabolic Cost of Exercise Initiation in Patients With Heart Failure With Preserved Ejection Fraction vs Community-Dwelling Adults.

Authors:  Ravi V Shah; Mark W Schoenike; Miguel Á Armengol de la Hoz; Thomas F Cunningham; Jasmine B Blodgett; Melissa Tanguay; John A Sbarbaro; Matthew Nayor; Jennifer Rouvina; Alyssa Kowal; Nicholas Houstis; Aaron L Baggish; Jennifer E Ho; Corey Hardin; Rajeev Malhotra; Martin G Larson; Ramachandran S Vasan; Gregory D Lewis
Journal:  JAMA Cardiol       Date:  2021-06-01       Impact factor: 14.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.